Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIV-GAMMA SN Inj. for Biliary Complications in ABO-Incompatible Liver Transplant
NCT05666453Phase 2Terminated
- Sponsor
- SK Plasma
- Start
- Apr 2022
- Primary completion
- May 2024
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of polyvalent human immunoglobulin, sponsored by SK Plasma. Started Apr 2022; status: terminated.
02
Drugs
polyvalent human immunoglobulin
Beyond the preview
Go deeper on NCT05666453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05666453.